Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer

Summary

RATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. PURPOSE: This clinical trial is studying how well cetuximab works in treating patients with Ménétrier disease at high risk of developing stomach cancer.

Timeline

Start

2001-04

Primary completion

2010-09

Completion

2010-09

Drugs

Indications